1Leykin Y, Pellis T, Lucca M, et al. The Pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg, 2004,99 : 1086-1089.
2Leykin Y,Pellis T, Lucca M, et al. The effects of cisatracurium on morbidly obese women. Anesth Analg, 2004,99:1090-1094.
4Gin T, Chan MT, Chan KL, et al. Prolonged neuromuscular block after rocuronium in postpartum patients. Anesth Analg, 2002,94:686-689.
5PUhringer FK, Keller C, Kleinsasser A, et al. Pharmacoki netics of rocuronium bromide in obese female patients. Eur J Anaesthesiol, 1999,16 : 507-510.
6Saitoh Y. Recovery from vecuronium is delayed in patients with hypercholesterolemia, Can J Anaestla, 2006,53 : 556 -561.
二级参考文献3
1Yamada T,Takino Y. A single bolus dose of vecuronium for rapid endotracheal intubation. Masui, 1992, 41:15-18.
2Russo R,Veschi G,Dellino E,et al. Onset time and duration of action of neuromuscular block induced by increasing doses of vecuronium bromide. Minerva Anesthesiol,1993, 59:35-38.
3Koscielniak-Nielsen ZJ, Bevan JC, Popovic V, et al.Onset of maximum neuromuscular block following succinylcholine or vecuronium in four age groups. Anesthesiology, 1993, 79:229-234.
8MILLER R D.Anesthesia[M].4th.New York:Churchill Livingstone,1994:1.
9DONLON J V,SAVARES J J,ALI H H,et al.Human dose-response curve for neuromuscular blocking drugs:A comparison of two methods of contrastion and analysis[J].Anesthesiology,1980,53(2):161-166.
